Fred Alger Management’s Atara Biotherapeutics ATRA Stock Holding History

Fred Alger Management’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-600	Closed	-$247K	–	550
2019 Q4	$247K	Hold	600	–	–	﹤0.01%	407
2019 Q3	$212K	Buy	+600	New	+$224K	﹤0.01%	402
2015 Q2	–	Sell	-216	Closed	-$224K	–	501
2015 Q1	$224K	Buy	+216	New	+$143K	﹤0.01%	609

Other funds holding ATRA

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

Fred Alger Management's ATRA Position: Q1 2020 in Review

Fred Alger Management sold out of Atara Biotherapeutics (ATRA) in Q1 2020, closing a stake of 600 shares — an estimated $247K sold.

Fred Alger Management first reported a position in ATRA in Q1 2015 and held it in 3 quarters. The position peaked at $247K in Q4 2019. 111 funds tracked by Wall St. Rank hold ATRA as of Q1 2020.

Fred Alger Management reported no remaining Atara Biotherapeutics position as of Q1 2020 after selling out during the quarter.
Fred Alger Management sold 600 Atara Biotherapeutics shares in Q1 2020, an estimated $247K.
Fred Alger Management first reported a position in Atara Biotherapeutics in Q1 2015 and held it in 3 quarters.
Fred Alger Management's Atara Biotherapeutics position peaked at $247K in Q4 2019.
111 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2020.

Based on Fred Alger Management's 13F filing for Q1 2020, filed 15 May 2020.